FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Telbivudine Tablets (TYZEKA)
Status: Discontinuation
»Therapeutic Categories: Antiviral

Novartis (New 09/30/2016)

Company Contact Information:
888-669-6682

Presentation Posting Date Related Information
Tyzeka (telbivudine) Film Coated Tablets 600 mg (bottle of 30) (NDC 0078-0538-15) 09/30/2016 Discontinuation of the product is not due to manufacturing, product quality, safety or efficacy concerns. Generic equivalents are not available, however other therapeutic alternatives available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English